Article ; Online: Transplantation programs facing lack of empirical evidence on SARS-CoV-2 vaccination: A society recommendation consensus update.
Transplant infectious disease : an official journal of the Transplantation Society
2021 Volume 23, Issue 4, Page(s) e13696
Abstract: ... of SARS-CoV-2 vaccination programs. We hereby offer a tool for immediate decision-making until empirical ... of the Society Recommendation Consensus score. The highest consensus level (SRC A) was found for prioritized ... international transplantation organizations and state institutions on SARS-CoV2 vaccination management ...
| Abstract | Background: Since phase III trials for the most prominent vaccines excluded immunocompromised or immunosuppressed patients, data on safety and efficacy of SARS-CoV-2 vaccines for recipients of solid organ transplantations are scarce. Aims: Our study offers a synthesis of expert opinions aligned with available data addressing key questions of the clinical management of SARS-CoV-2 vaccinations for transplant patients. Method: An online research was performed retrieving available recommendations by national and international transplantation organizations and state institutions on SARS-CoV2 vaccination management for transplant recipients. Results: Eleven key statements were identified from recommendations by 18 national and international societies, and consensus for the individual statements was evaluated by means of the Society Recommendation Consensus score. The highest consensus level (SRC A) was found for prioritized access to vaccination for transplant patients despite anticipation of a weakened immune response. All currently authorized vaccines can be considered safe for transplant patients (SRC A). The handling of immunosuppressive medication, the timely management of vaccines, and other aspects were aligned with available expert opinions. Conclusion: Expert consensus can be determined for crucial aspects of the implementation of SARS-CoV-2 vaccination programs. We hereby offer a tool for immediate decision-making until empirical data becomes available. |
|||||
|---|---|---|---|---|---|---|
| MeSH term(s) | COVID-19 ; COVID-19 Vaccines ; Consensus ; Humans ; RNA, Viral ; SARS-CoV-2 ; Vaccination | |||||
| Chemical Substances | COVID-19 Vaccines ; RNA, Viral | |||||
| Language | English | |||||
| Publishing date | 2021-07-28 | |||||
| Publishing country | Denmark | |||||
| Document type | Journal Article | |||||
| ZDB-ID | 1476094-0 | |||||
| ISSN | 1399-3062 ; 1398-2273 | |||||
| ISSN (online) | 1399-3062 | |||||
| ISSN | 1398-2273 | |||||
| DOI | 10.1111/tid.13696 | |||||
| Shelf mark |
|
|||||
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 5100: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.